LOGIN 
13 March 2023
We are a next-generation pricing and access company focused on innovation where there is an unmet need. At GPI we see a growing necessity for rapid decision making and pharmaceutical, biopharmaceutical and biotechnology companies are embracing technology to drive that decision making for better results.
GPI’s methodology is the industry’s first-ever predictive pricing model that helps companies forecast prices across global markets with accuracy and confidence. We have spent over four years developing the GPI methodology, which is designed to meet the demands of this rapidly evolving industry. We combine our advanced analytics, deep understanding of payer dynamics, and decades of experience in pricing and market access to create this powerful tool.
GPI’s data-driven methodology is the fastest way to determine market opportunity for your products. We predicted the price across key markets within a 10% range in oncology and immunology, which isn’t just powerful, but game changing. This innovative new solution accelerates decision making and reduces forecasting risk of strategic pricing and launch decisions.
We are preparing the future for better outcomes through data.
This e-book is a compilation of award-winning research that demonstrates the application of the horizon methodology through rapid value assessments against the backdrop of various scenarios.
PHARMACEUTICAL MARKET ACCESS & PRICING RESEARCH: KEY TRENDS & INDUSTRY DEVELOPMENTS
The pharma market access and pricing sector is an industry that has been undergoing significant change. This e-book presents the latest research on key trends and developments. It includes 7 insightful research abstracts that provide an overview of the current state of affairs, as well as future outlooks for the pharma market access and pricing sector.